Recursion Pharmaceuticals
RXRX
#3891
Rank
A$3.79 B
Marketcap
$9.44
Share price
-3.73%
Change (1 day)
-43.00%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Cash on Hand

Cash on Hand as of December 2024 : A$0.94 Billion

According to Recursion Pharmaceuticals's latest financial reports the company has A$0.94 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.95 B66.26%
2023-12-31A$0.57 B-28.88%
2022-12-31A$0.80 B13.41%
2021-12-31A$0.71 B109.01%
2020-12-31A$0.34 B241.54%
2019-12-31A$99.81 M